Bioequivalence: Issues and Options

Author： Midha Kamal K. Rawson Maureen J. Hubbard John W.

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.25, Iss.6, 1997-12, pp. : 743-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levothyroxine: therapeutic use and regulatory issues related to bioequivalence

By Wartofsky Leonard

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 727-732

Informa Healthcare

Access to resources Recommend Favorite

Statistical Issues in a Modeling Approach to Assessing Bioequivalence or PK Similarity with Presence of Sparsely Sampled Subjects

By Hu Chuanpu Moore Katy H. P. Kim Yong H. Sale Mark E.

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 4, 2004-08 ,pp. : 321-339

Springer Publishing Company

Access to resources Recommend Favorite

On the Determination of Bioequivalence

By Farolfi M. Powers J.D. Rescigno A.

Pharmacological Research, Vol. 39, Iss. 1, 1999-01 ,pp. : 1-4

Academic Press

Access to resources Recommend Favorite

Bioequivalence and Pharmacogenetics

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 4, 2013-12 ,pp. : 288-294

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Therapy for the Secondary Prevention of Stroke in Hypertensive Patients: Current Issues and Options

By Lüders Stephan

Drugs, Vol. 67, Iss. 7, 2007-01 ,pp. : 955-963

Adis International

Access to resources Recommend Favorite